We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Panel: More Data Required to Expand Clolar Use to Elderly
Panel: More Data Required to Expand Clolar Use to Elderly
September 1, 2009
The FDA’s Oncology Drugs Advisory Committee has voted 9–3 to recommend that Genzyme conduct a randomized, controlled trial of the company’s leukemia drug Clolar before the agency considers expanding the drug’s indications to include elderly patients.